Back to results
RecruitingPhase 2

A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

NCT07597629

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Affiliated Tumor Hospital of Harbin

Harbin, Heilonjiang, China

Contact

Clinical Trials Information Group officer

86-0311-69085587ctr-contact@cspc.cn
View on ClinicalTrials.gov
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer — TrialFind